Swiss National Bank’s Syndax Pharmaceuticals SNDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.54M | Buy |
164,300
+14,900
| +10% | +$140K | ﹤0.01% | 1939 |
|
|
2025
Q1 | $1.84M | Hold |
149,400
| – | – | ﹤0.01% | 1817 |
|
|
2024
Q4 | $1.98M | Hold |
149,400
| – | – | ﹤0.01% | 1863 |
|
|
2024
Q3 | $2.88M | Sell |
149,400
-1,200
| -0.8% | -$23.1K | ﹤0.01% | 1649 |
|
|
2024
Q2 | $3.09M | Hold |
150,600
| – | – | ﹤0.01% | 1571 |
|
|
2024
Q1 | $3.58M | Buy |
150,600
+8,200
| +6% | +$195K | ﹤0.01% | 1507 |
|
|
2023
Q4 | $3.08M | Buy |
142,400
+21,400
| +18% | +$462K | ﹤0.01% | 1600 |
|
|
2023
Q3 | $1.76M | Buy |
121,000
+1,700
| +1% | +$24.7K | ﹤0.01% | 1920 |
|
|
2023
Q2 | $2.5M | Buy |
119,300
+3,600
| +3% | +$75.3K | ﹤0.01% | 1743 |
|
|
2023
Q1 | $2.44M | Sell |
115,700
-13,700
| -11% | -$289K | ﹤0.01% | 1716 |
|
|
2022
Q4 | $3.29M | Buy |
129,400
+16,100
| +14% | +$410K | ﹤0.01% | 1570 |
|
|
2022
Q3 | $2.72M | Buy |
113,300
+8,100
| +8% | +$195K | ﹤0.01% | 1662 |
|
|
2022
Q2 | $2.02M | Buy |
105,200
+11,800
| +13% | +$227K | ﹤0.01% | 1910 |
|
|
2022
Q1 | $1.62M | Buy |
93,400
+8,100
| +9% | +$141K | ﹤0.01% | 2151 |
|
|
2021
Q4 | $1.87M | Hold |
85,300
| – | – | ﹤0.01% | 2110 |
|
|
2021
Q3 | $1.63M | Buy |
85,300
+2,200
| +3% | +$42K | ﹤0.01% | 2181 |
|
|
2021
Q2 | $1.43M | Buy |
83,100
+9,000
| +12% | +$155K | ﹤0.01% | 2303 |
|
|
2021
Q1 | $1.66M | Buy |
74,100
+900
| +1% | +$20.1K | ﹤0.01% | 2119 |
|
|
2020
Q4 | $1.63M | Buy |
+73,200
| New | +$1.63M | ﹤0.01% | 2026 |
|